Podcasts about life sciences

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Kaan-Fabian Kekec, Partner in Healthcare and Life Sciences at Simon-Kucher. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kaan, covering: Being on the sunny side of consulting, and helping clients unlock growth. What makes a key strategic partnership both from a CDMO, and a sponsor perspective. The taboo subject of pricing and how it can be used to help unlock commercial positioning, and excellence. Common mistakes in BD teams, and the importance of value positioning. The hottest segments in the market right now, and some of the competitive drivers in today's market. Kaan leads the firm's Healthcare B2B and Pharma Services business globally, encompassing CDMOs, CROs, bioprocessing solutions, drug delivery, packaging, and more. He specializes in delivering end-to-end commercial strategies for CDMOs, advising on growth initiatives and supporting clients throughout the entire lead-to-deal process—from marketing and sales to proposal management and deal optimization. Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.  Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

Many supplements claim to “boost” your immune system. Now, we all want to avoid getting sick during the winter months, but do any of these products really work? And is trying to “boost” your immune system even a good idea? Jonathan speaks with Professor Daniel M. Davis, MBE — a leading expert on immunology and Head of Life Sciences at Imperial College London. Daniel has published 145 scientific papers, authored four best-selling science books, and spent 25 years researching how our immune system works. He even helped discover the immune synapse, a breakthrough that changed our understanding of immunity. Daniel explains how your immune system really works, why it's connected to mental health, and how it can even detect cancer cells. He also clears up common myths and shares what genuinely helps keep your immune system strong through the winter months — and what won't make a difference. By the end of the episode, you'll know the practical, science-backed steps you can take to reduce your risk of colds and flu this winter without wasting money on products that don't deliver. Unwrap the truth about your food

In this episode, Seema Verma, EVP and GM of Oracle Health and Life Sciences, discusses Oracle's vision for transforming healthcare through AI, interoperability, and next-generation EHR technology. She shares insights on reducing administrative costs, advancing clinical research, improving prior authorization, and strengthening cybersecurity to create a more efficient and patient-centered system.This episode is sponsored by Oracle.

In this episode of Tiny Show and Tell Us, we talk about cute woolly mammoth mice and debate whether research to bring back extinct species (or their genes) is ethical or a good use of money and time. Then we discuss the best way to remove microplastics from water. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Melissa Wu, co-founder and CEO of Seeding Labs, a nonprofit that's redefining global scientific access. Dr. Wu shares the inspiring story of how Seeding Labs helps institutions in developing nations build research infrastructure by redistributing surplus laboratory equipment from partners like Thermo Fisher Scientific.With an innovative model that connects equipment donors in the global North with universities and institutes across Africa, Asia, and Latin America, Seeding Labs enables groundbreaking science in places where opportunity is limited but talent is abundant. Dr. Wu highlights examples like the Malawi University of Science and Technology, whose graduates are now staffing the country's first hospital microbiology labs, and a Beninese research team using donated PCR equipment to improve the yield of indigenous crops like the miracle berry.More than a logistics operation, Seeding Labs is also fostering scientific networks, reversing brain drain, and giving researchers confidence, courage, and agency. Dr. Wu offers a compelling vision of an equitable global scientific ecosystem, and shares how listeners can get involved—whether by donating equipment, funds, or simply spreading the word. Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

This episode is sponsored by Invivyd, Inc.Marc Elia is a biotech investor, the Chairman of the Board at Invivyd, and a Long COVID patient who decided to challenge the system while still stuck inside it. He's not here for corporate platitudes, regulatory shoulder shrugs, or vaccine-era gaslighting. This is not a conversation about politics, but it's about power and choice and the right to receive care and treatment no matter your condition.In this episode, we cover everything from broken clinical pathways to meme coins and the eternal shame of being old enough to remember Eastern Airlines. Marc talks about what it means to build tools instead of just complaining, what Long COVID has done to his body and his patience, and why the illusion of “choice” in healthcare is a luxury most patients don't have.This conversation doesn't ask for empathy. It demands it.RELATED LINKSMarc Elia on LinkedInInvivyd Company SiteMarc's Bio at InvivydFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textIn this episode, we will interview Dr. Thomas Cavaliere, the current Dean of the Rowan Virtua School of Osteopathic Medicine. Dr. Cavaliere graduated from the Des Moines University College of Osteopathic Medicine, following which he completed an internal medicine residency at Thomas Jefferson University Hospital. Under his leadership, the Rowan Virtua School of Osteopathic Medicine has been named one of the best medical schools in the country for primary care and geriatric medical education. Dr. Cavalierey has also recently been selected to serve as the inaugural Senior Vice Provost of the Virtua Health College of Medicine and Life Sciences, as well as the Chief Academic Officer for the Virtua Health System. It is an honor to interview such an accomplished physician, and we believe his perspectives are valuable for everyone from pre-medical students to attending physicians. Dr. Cavaliere will discuss the advantages of pursuing a career in academic medicine, emphasizing the opportunity to combine clinical practice with teaching and research, and the fulfillment of caring for patients while training the next generation of physicians. We know you will love this episode.

As clinical research becomes increasingly digital, the legal and compliance landscape is shifting. Hal Porter, Director of Consulting Services, Clearwater, speaks with Dianne Bourque, Partner, Holland & Knight LLP, about the legal, regulatory, and ethical considerations when clinical trial data is compromised. They discuss issues related to regulatory frameworks and legal obligations, risk exposure and liability, impacts of a breach that go beyond privacy, cross border data and transfer risks, and mitigating the risk and fallout of data breaches in clinical trials. Sponsored by Clearwater.Watch this episode: https://youtu.be/XwtZXXGmLx4Learn more about Clearwater: https://clearwatersecurity.com/ Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Jan de Kerpel is Manager Director en Hoofd Life Sciences bij Van Lanschot Kempen.***Volg Leaders in Life Sciences via de website.Volg Leaders in Life Sciences via LinkedIn.Bezoek www.henkjanout.nl voor meer informatie over de host.***Vragen, suggesties of feedback? Graag! Stuur een email naar: henkjan.out@me.com***Vind jij de Leaders in Life Sciences podcast leuk? Dan zouden we het enorm waarderen als je een recensie zou willen achterlaten op Apple Podcasts of een vijf sterren beoordeling zou willen geven op Spotify.Jouw steun betekent veel voor ons, omdat het anderen kan aanmoedigen om de podcast ook te gaan beluisteren. Heel erg bedankt!***Leaders in Life Sciences wordt mede mogelijk gemaakt door Pivot Park, Pedersen & Partners en Johnson & Johnson Innovative Medicine.

Ádám Ildikó, az EY Magyarország Partnere, a 33 országot magába foglaló Europe Central régió Life Sciences – élettudományok – iparági fókuszterület vezetője volt az EY Agenda Podcast legújabb adásának vendége.Ildivel beszélgettünk az adózás és az egészségügy összefüggéseiről, az egészség-gazdaságtan kihívásairól, karrierről és a vízióját is elárulta. Az adásból többek között kiderül:Hogyan lehet karriert építeni egy specifikus területen?Hogyan teremt valódi értéket az adó- és állami támogatásokkal kapcsolatos tanácsadás?Milyen hatással van az AI és a vámháború az élettudományokra?Lehet egyensúlyt találni egy régiós vezetői pozíció, a PhD tanulmányok és a magánélet között?

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Adam Siebert, Managing Director and Partner at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering: Adam's journey from academic to commercial, and what helped him transition into 'life science enablers". How pandemic demand has left our sector with a huge over capacity issue and market imbalance. Some positive signals for the second half of 2025 after a period of geopolitical chaos, and a bumpy rollercoaster. Even thought biotech funding has largely returned... how decreasing clinical trials, a shifting of therapeutic focus, and the concentration of investments on fewer, higher value deals is impacting pharma services. The value of building a reputation in one in-demand modality area before extending into other modalities. And why the CDMO is at an inflexion point... Adam is a Managing Director and Partner in L.E.K. Consulting's New York office and a member of the Life Sciences practice. He has been with L.E.K. for over eight years, and has experience across diagnostics and research tools, bioprocessing and pharma services, and emerging, mid-cap and large pharma. Adam has helped a number of clients in the life sciences industry with growth strategy, life cycle management, portfolio optimization and M&A projects. Adam holds a Bachelor of Science from Boston College and a Ph.D. from the Perelman School of Medicine at the University of Pennsylvania.    Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.

To mark our 200th episode, we are taking you into Space to discover the benefits of microgravity for health and medical research and its real-world applications. Can we use space technology to advance medical discoveries to improve health here on earth? And should we be doing more to connect our life science sector innovators into Australia's space research sector?We meet leading Australian superstars working at the intersection of space and health technologies at MTPConnect SA's Insights Series event “What's Your Place in Space', celebrating Australian Space Week in Adelaide.Australia's first astronaut, Katherine Bennell-Pegg, Director of Space Technology at the Australian Space Agency shares her view on why space matters, and the role of astronauts on the International Space Station as scientists in space. She reveals how biotech research in space using microgravity is revolutionising pharmaceutical development and unlocking treatments for cancer here on Earth.Aerospace medicine specialist Dr Gordon Cable from Human Aerospace, is working on a spacesuit design program, developing compression garments that "trick" the body into thinking gravity exists, with applications for burns, lymphedema and post-surgical recovery. Dr Richard Harvey from the ARC Centre of Excellence in Plants for Space explains how the international research consortium is engineering smart plants in space labs, that operate as programmable biological factories for biomolecule synthesis, to produce pharmaceuticals, including compounds that protect against radiation and improve cancer therapies. And Tiffany Sharp from Cambrian Defence and Space discusses launching medical research into space on a rocket in the Arctic circle - looking into the gut microbiome which shows how certain bacteria affecting anxiety and depression decline in microgravity, offering insights for mental health treatments.

Nicolas Wolikow will die Ausnahme zur Regel machen – und Krebs neu verstehen Nicolas Wolikow ist französischer Unternehmer und Mitgründer sowie CEO von Cure51, einem Health‑Tech/TechBio‑Unternehmen, das die erste weltweite Datenbank außergewöhnlicher Krebspatient:innen („Exceptional Survivors“) aufbaut und daraus neuartige Therapieansätze entwickelt. Er verfügt über mehr als zwei Jahrzehnte Erfahrung in digitalen Geschäftsmodellen, Technologie und Life Sciences. […] Der Beitrag Nicolas Wolikow – Wie Cure51 das Überleben bei Krebs entschlüsseln will erschien zuerst auf Visionäre der Gesundheit.

After years of carrying the weight of lead, Shannon and Cooper find a path out from under the darkness and into the sunlight.LEAD: how this story ends is up to us is an audio docudrama series that tells the true story of one child, his mysterious lead poisoning, and his mother's unwavering fight to keep him safe. A true story written by Shannon Burkett. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.Lead was produced by Shannon Burkett. Co-produced by Jenny Maguire. Featuring Amy Acker, Tom Butler, Dennis T. Carnegie, James Carpinello, Geneva Carr, Dann Fink, Alice Kris, Adriane Lenox, Katie O'Sullivan, Greg Pirenti, Armando Riesco, Shirley Rumierk, Thom Sesma, and Lana Young. Music by Peter Salett. “Joy In Resistance” written by Abena Koomson-Davis and performed by Resistance Revival Chorus. Casting by Alaine Alldaffer and Lisa Donadio. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Sounds of Science, learn how the Retrogenix® platform is reshaping drug development by identifying off-target risks earlier, reducing animal use, and gaining traction with regulators—now as part of the FDA's ISTAND pilot program. Guests Nick Brown and Mark Aspinall-O'Dea from Charles River Discovery Services share real-world insights on their role in advancing NAMs and supporting safer, faster therapeutic development.Show Notes Maximize Safer, Targeted Biologic Development with Smarter NAMs-Based Off-Target Screening Paving the Way for Enhanced Drug Development A Status Report on Cell-Based Protein Arrays Retrogenix® Human Protein Library Retrogenix®: The Screen Door of Drug Development Retrogenix® CAR Specificity Testing Charles River Launched New Retrogenix Non-Human Protein Library 

This week, we went to the doctor. Oz speaks with Dr. Matthew Lungren, the Chief Scientific Officer for Microsoft Health & Life Sciences, who co-authored a study showing that AI diagnosed complex medical cases four times faster than human doctors. Dr. Lungren walked us through how multiple AI agents worked together to generate their diagnoses, what that means for the future of medicine—and how human doctors and AI could collaborate to build a more democratized healthcare system.See omnystudio.com/listener for privacy information.

In this episode of Tiny Show and Tell Us, we talk about a new and exciting biodegradable polymer that seems to outperform commercial super glues. Then we discuss a compound called sulfur hexafluoride (SF6) that is used in high voltage equipment. Not only is SF6 a potent greenhouse gas, if you breathe it in it has the opposite effect of helium — it makes your voice deep. But it can also lead to asphyxiation so you should not breathe it in. We repeat: do not breathe this gas in. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The new season of Business Class News's Race to the Start Line podcast launched with a conversation that was both deeply personal and profoundly forward-looking. Host Karl Woolfenden sat down with two leaders from Caris Life Sciences—Dr. David Spetzler, President and Chief Scientific Officer, and Dr. James Hamrick, Chairman of the Caris Precision Oncology Alliance —for a discussion on how Caris is transforming the future of cancer care. Woolfenden framed the conversation with personal reflections, sharing how recent losses in his own circle to cancer heightened his awareness of the need for innovation in oncology. “It tightened my awareness,” he said, “of how important it is to spotlight the companies and individuals driving meaningful progress.” Tackling the Complexity of Cancer Caris Life Sciences is a leader in molecular profiling and precision medicine, advancing how oncologists understand and treat cancer. Dr. Spetzler emphasized just how complicated this mission is: “Yeah, so I think what the patents demonstrate is that we're really on the cutting edge of trying to understand cancer. And the complexity of cancer is really quite staggering, because there are no two diseases that are the same.” He explained that Caris has built one of the world's largest datasets in cancer biology. “One of the things that we've been able to do is amass an enormous data set. We're approaching having profiled a million patients, and one of the great advantages that gives us is we can start to understand—from previous patients—new patients' status, and direct them towards the better drugs that are going to help them live longer.” From Science to the Patient Bedside Where Spetzler focused on the science, Dr. James Hamrick provided a clinical lens on the company's work. He reflected on his journey as both a practicing oncologist and now a leader at Caris. “The founder of Caris, and Dr. Spetzler who has been there since 2009, was always that connection point between the science and the patient. And that's where I focus—making sure what we're doing actually makes a difference in the clinic.” Hamrick highlighted the importance of ensuring that breakthroughs aren't confined to research institutions but are accessible to patients everywhere: “Too often, patients in community hospitals don't benefit from the latest advancements available at large academic medical centers. At Caris, we're working to close that gap.” Humanizing the Science The conversation underscored the human stakes of the work. Both leaders emphasized that the mission isn't just about data or discovery—it's about outcomes. Dr. Spetzler summed it up: “Science is only as valuable as the difference it makes in the real world. That's what drives us every day.” Scaling Innovation for the Future For Caris, growth means more than company expansion—it means scaling the reach of its technology so that physicians everywhere have the tools to personalize cancer care. This, Woolfenden pointed out, is a different kind of “race to the start line”: one where the finish line is measured in lives saved and futures extended. As the first episode in the series, the dialogue with Caris Life Sciences set a high standard for Race to the Start Line. It showcased how innovation, when combined with purpose, can shape industries—and in this case, save lives. 

The deficits from the lead poisoning continue to intensify, Shannon channels her anger and grief into holding the people who hurt her son responsible.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.EP4 features Eboni Booth, Sasha Eden, Kevin Kane, April Matthis, Alysia Reiner, and Mandy Siegfried. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Laura welcomes Dr. Esther Sternberg, M.D., a Professor, Research Director, Speaker, and Author of the books Well at Work, Healing Spaces, and The Balance Within, to the podcast to talk about wellness at work and how workplace environments impact employees. Dr. Sternberg shares her career journey from her start in medical family practice through to becoming the Research Director at the Andrew Weil Center of Integrative Medicine. She and Dr. Laura talk about what factors impact health and overall wellness at work and how these can be improved.Dr. Sternberg delves into the insights in her book Well at Work and explains the seven domains of integrative health as defined by the Andrew Weil Center for Integrative Medicine. Sleep, resilience, environment, movement, relationships, spirituality, and nutrition are the seven domains, and they include things like how quickly we bounce back from stress, how clean our air is, and access to nature. Dr. Laura and Dr. Sternberg examine how office design, environmental location, common spaces that encourage relationships, and even temperature all play a key role in our workplace health. The conversation sheds light on how work isn't simply a place to invest time into productivity, but can positively or negatively impact our overall lives, and how redefining workplaces is a vital part of future discussions. “... if you're feeling too stressed or too activated, you want to do something that will tone down that stress response so you can perform at peak... If you're too stressed, you freeze, you're unable to focus. You're unable to do the job, the task at hand. So what helps you to move that stress response from the extreme danger zone back to performing at peak is places where you can go offline a little bit, where you can effectively meditate even though you're not sitting there with crossed legs in a lotus position in a yoga studio, although having spaces where some people can do that is is also beneficial. But a space, for example, [like] the gardens. To just walk in the gardens, to just take your brain off the computer for a while and focus on the green, on the plants.” - Dr. Esther SternbergAbout Dr. Esther Sternberg, M.D.:Dr. Esther Sternberg is internationally recognized for her discoveries in the science of the mind-body interaction in illness and healing, and the role of place in wellbeing. She is a pioneer and major force in collaborative initiatives on mind-body-stress-wellness and environment interrelationships. A dynamic speaker, she engages her audience with passion for her subject and compassion as a physician. Through stories, she provides listeners with many take-home tips to help them cope with stress and thrive, and to create wellbeing spaces wherever they work or live. Dr. Sternberg's three popular, highly readable, informative, and scientifically based books are inspirations for lay persons and professionals alike, seeking answers to the complexities and 21st-century frontiers of stress, place, healing, and wellness. Her award-winning book, WELL at WORK: Creating Wellbeing in Any Workspace (Little, Brown Spark, 2023) was named a Top Ten Lifestyle Book for Fall 2023 by Publishers Weekly and received the OWL (Outstanding Works of Literature) Longlist Award. Her two previous science-for-the-lay public books, Healing Spaces: The Science of Place and Well-Being and The Balance Within: The Science Connecting Health and Emotions, are landmark in its field. Healing Spaces was recognized by the President of the American Institute of Architects as an inspiration for launching the AIA's Design and Health Initiative and has inspired the implementation of healing spaces in hospitals across the country and around the world. Currently, Research Director, Andrew Weil Center for Integrative Medicine and Founding Director of the University of Arizona Institute on Place, Wellbeing & Performance, she holds the Inaugural Andrew Weil Chair for Research in Integrative Medicine and is a Research Professor of Medicine with joint appointments as Professor in Psychology, Architecture, and Planning & Landscape Architecture, and in the College of Agriculture and Life Sciences, School of Nutritional Sciences and Wellness. As Senior Scientist and Section Chief, National Institutes of Health (1986-2012), she directed the NIH Integrative Neural Immune Program, Co-Chaired the NIH Intramural Program on Research on Women's Health, and chaired a subcommittee of the NIH Central Tenure Committee. Dr. Sternberg has advised the World Health Organization; the U.S. National Academies of Sciences, Engineering and Medicine; the International WELL Building Institute; the Royal Society, London; the Vatican, where she was presented to Pope Benedict XVI; and has briefed high-level U.S. Federal Government officials, including the Surgeon General, National Institutes of Health leadership, and the Department of Defence. Her two decades-long research with the U.S. General Services Administration, using wearable devices to track health and wellbeing in the built office environment, is informing healthy design standards and COVID re-entry across the federal government and the private sector.Among other honors, she moderated a panel with the Dalai Lama, was recognized by the National Library of Medicine as one of the women who “Changed the Face of Medicine,” served as a member and Chair of NLM's Board of Regents, and received an Honorary Doctorate in Medicine from Trinity College, Dublin, on its 300th Anniversary. She has authored over 240 scholarly articles, edited 10 technical books on the topic of brain-immune connections and design and health, and writes a monthly blog for Psychology Today, it has garnered tens of thousands of readers on subjects including stress and illness, gratitude and wellness, and place and wellbeing. She co-created and hosted the PBS Television Special, The Science of Healing with Dr. Esther Sternberg, and is frequently interviewed in the lay press and media, including NPR, BBC, CBC radio; PBS, ABC, CBS 60 Minutes, Overtime television, the Washington Post, LA Times, U.S. News and World Report, Reader's Digest, Prevention Magazine, The Oprah Magazine, and numerous podcasts, among others. She received her M.D. from McGill University, and trained in rheumatology at the Royal Victoria Hospital, Montreal, Canada.Resources:Website: EstherSternberg.comBook: “Well at Work: Creating Wellbeing in any Workspace” by Esther M. Sternberg, MDInstagram: @dresternbergLinkedInLearn more about Dr. Laura on her website: https://drlaura.liveFor more resources, look into Dr. Laura's organizations: Canada Career CounsellingSynthesis Psychology

In today's Cloud Wars Minute, I explain how Oracle is transforming healthcare with its AI-driven, cloud-native EHR, setting a bold path toward intelligent care.Highlights00:02 — Oracle has introduced an updated version of Oracle Health EHR, or Electronic Health Record, for ambulatory providers in the U.S., built on Oracle Cloud Infrastructure. The new system features native AI agents that operate together as an orchestrated system for maximum process efficiency.00:29 — The new Oracle Health EHR, was designed in collaboration with frontline providers and delivers the services that they require in a manner that's most useful to them. For example, it features personalized, streamlined workflows. In 2026, Oracle plans to enhance the system to include acute care, further expanding the reach of this groundbreaking technology.00:50 — Now, this represents a major leap forward for healthcare providers, and Oracle is right to focus significant efforts in this direction, enabling clinicians to cut through the administrative burdens of the healthcare industry. Identified as one of the first major use cases for generative AI, it remains a priority, and Oracle is certainly thinking big in this area.01:13 — In fact, Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, said the following: "When Oracle committed to transforming the healthcare industry, we knew we had to start with the EHR." Note the commitment to not just supporting, but "transforming" the healthcare industry. Visit Cloud Wars for more.

Matters Microbial #104: Antibiotic “Tolerance” and Biofilms August 21, 2025 Today, Dr. Boo Shan Tseng, Associate Professor at the University of Nevada Las Vegas School of Life Sciences, joins the #QualityQuorum to discuss bacterial biofilms and antibiotic tolerance.  Host: Mark O. Martin Guest: Boo Shan Tseng Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video overview of biofilms. A comprehensive review article on biofilms. An article describing the impact biofilms have on disease. An article describing the impact of biofilms on implanted medical devices. A link to the Center for Biofilm Engineering at Montana State University that has MANY links of interest. An overview of biofilm development. An overview of confocal laser microscopy. Studying biofilms in flow cells. An article about the role proteins play in biofilm formation, which intersects with the Tseng group's research. The technique of single cell RNA seq. The technique of mRNA-FISH. An article about porins in bacteria, and how that can relate to antibiotic resistance. An article by Dr. Tseng and coworkers on the eDNA and biofilms discussed today. A lovely video of Dr. Tseng talking about the research she and her colleagues carry out in the laboratory. Dr. Tseng's biography from the American Society for Microbiology. Dr. Tseng's laboratory group website with wonderful links and images. Dr. Tseng's faculty website. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Jim talks with Lawrence Cahoone about the ideas in his book The Orders of Nature: An Introduction to the Philosophy of Complex Systems for the Life Sciences. They discuss how Cahoone's naturalist philosophy bridges multiple philosophical domains, his distinctive use of emergence theory borrowed from William Wimsatt, the concept of "no simples" in objective relativism, the role of Prigogine in emergence theory, Cahoone's self-taught approach to understanding physics and science, fallibilist and local metaphysics, Columbian naturalism and its rejection of the supernatural, the relationship between objects and their contexts, scientific explanations of relativity and quantum mechanics, and much more. Episode Transcript The Orders of Nature: An Introduction to the Philosophy of Complex Systems for the Life Sciences, by Lawrence Cahoone The Emergence of Value: Human Norms in a Natural World, by Lawrence Cahoone The Feynman Lectures on Physics, by Richard Feynman Lawrence Cahoone graduated with a Ph.D. in Philosophy at Stony Brook University in 1985. Cahoone's areas of specialization are American Philosophy, Continental Philosophy, Social and Political Philosophy, Philosophy of Culture, Metaphysics and Natural Science and Modernism and Postmodernism. Since 2000, Cahoone has taught at Holy Cross and is now currently an Emeritus Professor of Philosophy at Holy Cross. He has also written and published seven books in his career, including The Emergence of Value, The Orders of Nature, and Cultural Revolutions.

After some years developing websites and interactive and digital marketing projects, Guillem joined Merck in 2009, and he has been always related to digital marketing projects on the business side. Since 2020 Guillem has been driving the Social Selling initiative for Merck Life Science, focusing on Social Scouting with LinkedIn Sales Navigator, Social Listening and Employee Advocacy, to help Sales teams be more effective by using social channels to uncover new business opportunities. His work with using Chat CPT to support employee content has been truly inspiring with some great results. Folllow him on Linkedin for more https://www.linkedin.com/in/guillemcardenal/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Hamid Ghanadan, CEO at LINUS, reports on their recent State of Science research that tracks scientists' sentiment, funding expectations, and barriers to their work. Key findings reveal that the politicization of science and erosion of public trust in science threaten to slow innovation rates and negatively impact public access to accurate information. The survey also shows a direct negative impact on scientists' morale, job satisfaction, and creativity. We talk about: The growing perception of the public that science is not real Sources of public distrust of scientific information When scientists become politically active  Need for more direct communication from the scientists and life science leaders to make complex topics more understandable and relevant Opportunity for researchers, institutions, vendors, and advocacy groups to recognize these issues and take responsibility to improve the communication of accurate health and medical information to a broader audience #TheLINUSGroup #Scientists #MedicalResearchers #PublicTrust #PoliticizationofScience #HealthcareInformation #MedicalInformation  TheLINUSGroup.com

An estimated 132 million babies were born across the globe last year — really just a drop in the bucket when you think about the over 100 billion babies born since modern humans first lived on Earth 200,000 years ago. And until very recently we had few tools to understand how they were doing in the womb, how they would fare in the days after birth, and how a pregnant person would change physically and mentally not just during pregnancy but in the months and years that followed. Things have changed dramatically, particularly over the last decade, in terms of the care and technology that's available preconception, during pregnancy, and post-birth. But there is still so much we don't know about these time periods, both for baby and mom, and many a black box remains. Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of Digital Squared: From the Archives, we're revisiting a conversation with Ed Marx, Chief Digital Officer for Tech Mahindra Health and Life Sciences and formerly the CIO at Cleveland Clinic and NYC Health & Hospitals. Ed is full of enthusiasm, curiosity and drive, and he has used those tools to expand his own horizons and to act as catalyst to define the role of the post-modern CIO for the healthcare industry.

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“More technology, more life science and healthcare:” Scott Sperling believes these are what will fuel the future. He also sees opportunities in logistics and thinks more businesses will “fundamentally tweak” their models with technology to become more efficient and prosperous. On the Fed, he says the best option is a 25 basis point rate cut in September. He also brings the case that the Fed is losing control over the 10-year.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Welcome to Automating Quality, the life sciences–focused show that bridges the gap between automation and quality management. In today's episode, our host Philippe welcomes Jim Ferguson, President and Owner of NuQual Consulting. With over 25 years of experience in the life sciences industry, Jim brings deep expertise in supplier quality and compliance. Together, they dive into the world of internal audits — how they can be used not only to maintain compliance but also to proactively identify and resolve potential observations before a regulatory inspection takes place.   Key Takeaways 01:22 Introducing today's guest, Jim Ferguson from NuQual Consulting 02:18 What quality-focused events has Jim been attending lately? 04:30 How can internal audits help organizations prepare for regulatory inspections or other types of audits? 07:25 What is the value of outsourcing internal audits? 08:35 How can companies ensure that audit findings actually lead to meaningful changes? 12:57 What does a strong response to internal audit findings look like? 17:30 What are some common pitfalls organizations tend to overlook during internal audits?   Contact Jim at https://nuqualconsulting.ca/ Contact us at solabs-podcast@solabs.com

  The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity. Greg Slabodkin   Read by Brittany Duncan    https://www.pharmamanufacturing.com/all-articles/article/55308250/new-jersey-remains-hot-life-sciences-hub-despite-macroeconomic-funding-headwinds 

McAndrew Rudisill, Board Chair for ETHZilla, joined me to discuss ETHZilla's Ethereum corporate treasury.Topics:- 180 Life Sciences Corp rebrand to ETHZilla - Choosing Ethereum as a treasury asset - Ethereum staking and DeFi - Crypto Treasury strategy risks - Crypto Legislation & Market Outlook 

Jack Moody is back hosting this week and we catch up on the racing from the weekend. We revisit our interview with Dr. Philip Hurst, former middle-distance runner and current academic from the School of Psychology and Life Sciences at Canterbury University. We discuss the intriguing world of the 'placebo effect', its negative counterpart - the 'nocebo effect' and their impact on sports performance. Drawing from his research and experience, Dr. Hurst shares the significance of these effects in the medical world and how they have the potential to shape athlete performance. (0:00:00) – Calling in from Prague (0:04:20) – Prague – a wetsuit race (0:06:41) – Charlotte McLauchlan study  (0:09:08) – IM703 Melbourne competition                        (0:11:12) – Racing from the weekend (0:24:22) – IM703 Hradec-Kralove (Prague) (0:43:04) – Dr Philip Hurst LINKS: Follow Jack Moody on Instagram at https://www.instagram.com/jacktmoody/ Dr Philip Hurst's review “The Placebo and Nocebo effect on sports performance: A systematic review” at https://pubmed.ncbi.nlm.nih.gov/31414966/ Follow Dr Philip Hurst on Twitter at https://twitter.com/Phil_Hurst1 IRONMAN 70.3 Hradec-Kralove (Prague) at https://www.ironman.com/races/im703-hradec-kralove Charlotte McLauchlan can be contacted by email at cmcl126@aucklanduni.ac.nz Fitter Radio Episode 613 – Interview with Charlotte McLauchlan at https://www.fitter.co.nz/fitter-radio/2025/4/12/episode-613-confidence-nutrition-and-the-mind Plasmaide at https://plasmaide.com/

Melissa Sleeper is a National Board Certified Teacher currently teaching Life Science and Space Science at Holy Trinity Episcopal Academy in Melbourne, Florida. A career changer, Melissa worked as an Agriculture Economist/Statistician setting up crop reporting services and running rural household surveys. She lived and taught in both public and private schools in Morocco, Egypt, Grenada, Barbados, Bolivia, and Nicaragua in addition to her extensive work here in the States. Melissa has the unique experience of being able to say she has taught at every grade level from pre-K to adult.. Melissa an active member of the National Science Teaching Association, The AIAA and has served on, among others, the Aerospace Advisory Board and National Middle Level Science Teachers Association. Her passion for space education was flamed when she was selected an Educator Ambassador for NASA's MAVEN Mission. We are grateful to know such a passionate STEM educator and we know you will appreciate Melissa as much as we do. SmallSat Education Conference:

AI systems can do amazing things, but they can sometimes suffer from a drawback called “catastrophic forgetting”. Researchers at Arizona State University hope to learn how to solve the problem by probing the brains of sleeping bees. The pay-off could be more reliable, more memory-efficient artificial intelligence. When AI systems learn one task — say, how to recognize dogs — and are later trained on a new task — like identifying cars — they often forget the first thing they learned. This is called ctastrophic forgetting. Ted Pavlic is an associate professor of computer science and engineering in the School of Computing and Augmented Intelligence, part of the Ira A. Fulton Schools of Engineering at ASU, with a joint appointment in the School of Life Sciences. He leads a unique interdisciplinary research project that blends biology and computer science.

Building Maryland's BioHealth Future: Maryland Commerce's Stefanie Trop on Growing the Life Sciences Sector In this episode of BioTalk with Rich Bendis, Stefanie Trop, Ph.D., Director of Life Sciences at the Maryland Department of Commerce joins the conversation to discuss Maryland's position as a leading life sciences hub. Stefanie shares how the Department of Commerce supports company attraction and growth through programs like Global Gateway, and how it's amplifying the state's recent #3 biopharma hub ranking. The discussion also explores Maryland's unique ecosystem, including the work of the Governor's Life Sciences Advisory Board, the state's leadership in computational health, and the importance of industry collaboration during BioHealth Capital Region Week. Editing and post-production work for this episode was provided by The Podcast Consultant. Dr. Stefanie Trop brings a unique blend of hands-on scientific expertise and high-level strategic insight. With a Ph.D. in Molecular Microbiology and Immunology, she has worked at the ground level in immunology, clinical trials, and vaccine development, while also driving growth through scientific partnerships and business development. Her deep understanding of the science and passion for problem solving guides her ability to build effective collaborations that advance both innovation and commercial success. At the Maryland Department of Commerce, Stefanie works to connect Maryland's life sciences companies with national and global resources, expanding the industry's impact at home and globally. In current and prior roles, she bridges communication gaps between scientific and business teams, ensuring that customer needs translate into innovative products and business wins.

As AI becomes deeply embedded in every industry, building AI systems that are secure, responsible, and privacy-centric is more crucial than ever. But where do you begin? At the strategy level? Design? Or implementation? How do organizations tackle the challenges of AI risks, data governance, and compliance while keeping pace with innovation?Join us for an insightful conversation with Punit Bhatia and Santosh Kaveti, CEO of Pro Arch, as we explore the evolving landscape of responsible AI, key foundational steps, and the practical approaches to secure AI deployment.If you're looking to understand how to build AI systems that are not only innovative but also secure and trustworthy, this episode is for you!KEY CONVERSION 00:01:58 Responsible AI 00:04:30 AI Strategy 00:11:43 Role of standards and Approach 00:15:35 Good practices of Data Governance 00:19:55 AI Talent 00:23:10 Pro Arch Role in costumers 00:25:00 Contact Information of Santosh  ABOUT GUEST Santosh Kaveti is CEO & Founder at Proarch. With over 18 years of experience as a technologist, entrepreneur, investor, and advisor, Santosh Kaveti is the CEO and Founder of ProArch, a purpose-driven enterprise that accelerates value and increases resilience for its clients with consulting and technology services, enabled by cloud, guided by data, fueled by apps, and secured by design. Santosh's vision and leadership have propelled ProArch to become a dominant force in key industry verticals, such as Energy, Healthcare & Lifesciences, and Manufacturing, where he leverages his expertise in manufacturing process improvement, mentoring, and consulting. Operationalizing AI: From Strategy to Execution Navigating AI Risks: Ensuring Security and Compliance Prioritizing AI Initiatives: Aligning with Business Goals Attracting and Retaining Top AI Talent Integrating AI into Core Business Functions The Data Foundation: Governance, Quality, and Culture in AI  Santosh's journey is marked by resilience, ambition, and self-awareness, as he has learned from his successes and failures, and continuously evolved his skills and perspective. He has traveled across 23 countries, gaining insights into the global diversity and interconnectedness of human experiences. He is passionate about blending technology with a human-centric approach and making a meaningful societal impact through his support for initiatives that uplift underprivileged children, assist disadvantaged families, and promote social awareness.Santosh's ethos extends to his investments in and mentorship of promising startups, as well as his role as the Chairman of the Board at Enhops and iV4, two ProArch companies.  ABOUT HOST Punit Bhatia is one of the leading privacy experts who works independently and has worked with professionals in over 30 countries. Punit works with business and privacy leaders to create an organization culture with high privacy awareness and compliance as a business priority. Selectively, Punit is open to mentor and coach professionals.  Punit is the author of books “Be Ready for GDPR' which was rated as the best GDPR Book, “AI & Privacy – How to Find Balance”, “Intro To GDPR”, and “Be an Effective DPO”. Punit is a global speaker who has spoken at over 30 global events. Punit is the creator and host of the FIT4PRIVACY Podcast. This podcast has been featured amongst top GDPR and privacy podcasts.  As a person, Punit is an avid thinker and believes in thinking, believing, and acting in line with one's value to have joy in life. He has developed the philosophy named ‘ABC for joy of life' which passionately shares. Punit is based out of Belgium, the heart of Europe.  RESOURCES Websites www.fit4privacy.com,www.punitbhatia.com, https://www.linkedin.com/in/santoshkaveti/ , https://www.proarch.com/  Podcast https://www.fit4privacy.com/podcast Blog https://www.fit4privacy.com/blog YouTube http://youtube.com/fit4privacy   

ETHZilla is one of the latest companies to take a page from the MicroStrategy playbook and completely transform into a crypto treasury firm. ETHZilla, currently trading under its original name 180 Life Sciences, just scored a significant investment from Peter Thiel, whose associated funds amassed a 7.5% stake. That news, paired with the announcement that ETHZilla is now holding more than 82,000 ETH, caused the stock to more than triple in a single day. Executive Chairman McAndrew Rudisill speaks with host Zaid Admani about the company's vision for ethereum and what Peter Thiel's investment signals about the future of the digital asset.The content of the video is for general and informational purposes only. All views presented in this show reflect the opinions of the guest and the host. You should not take a mention of any asset, be it cryptocurrency or a publicly traded security as a recommendation to buy, sell or hold that cryptocurrency or security. Guests and hosts are not affiliated with or endorsed by Public Holdings or its subsidiaries. You should make your own financial and investment decisions or consult respective professionals. Full disclosures are in the channel description. Learn more at Public.com/disclosures.Past performance is not a guarantee of future results. There is a possibility of loss with any investment. Historical or hypothetical performance results, if mentioned, are presented for illustrative purposes only. Do not infer or assume that any securities, sectors or markets described in the videos were or will be profitable. Any statements of future expectations and other forward-looking statements are strictly based on the current views, opinion, or assumptions of the person presenting them, and should not be taken as an indicator of performance nor should be relied upon as an investment advice.

In this episode of Tiny Show and Tell Us, we talk about breathing in birds — how it takes two breath cycles for air to leave their bodies, and while it travels within their bodies, it's stored in various sacks, some of which are in their butts. Then we discuss how food waste contributes to approximately 8% of global greenhouse gas emissions every year, and what we can do to reduce it. We need your stories — they're what make these bonus episodes possible! Write in to tinymatters@acs.org *or fill out this form* with your favorite science fact or science news story for a chance to be featured.A transcript and references for this episode can be found at acs.org/tinymatters.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's guest is Dr. Steffen Hoffmann, Managing Director of Bosch UK. Dr. Hoffmann joins Emerj Editorial Director Matthew DeMello to explore the strategic deployment of AI across industrial sectors, from manufacturing operations to internal business systems. Dr. Hoffmann shares how AI is helping manufacturers address upstream process variables to reduce defect rates and improve efficiency. He also discusses the importance of “human in the loop” oversight in regulated environments, and how Bosch's internal deployment of generative AI — starting with an HR assistant — serves as a model for cautious, business-aligned innovation. The conversation explores industrial applications of AI governance, the role of internal use cases in de-risking new technologies, and the broader cultural conversation around balancing AI's risks and rewards. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Predictable hiring isn't just possible —it's essential. On this episode, host Ryan Dull is joined by Michael Peterson, Sr. Director of Global Talent Acquisition – Talent Sourcing, Intelligence and Innovation at Edwards Lifesciences, to explore how strategic planning, data-driven practices and a consumer-minded approach are shaping modern TA functions in highly regulated industries. Michael walks through his path from aspiring pilot to TA leadership, sharing lessons from roles across healthcare, tech and international organizations. From building teams from scratch to redefining success metrics, Michael also offers practical insights into the evolving TA landscape.Key Takeaways:(00.00) Introduction.(02:35) Michael pivoted from aviation to a career in TA leadership.(04:48) Edwards Lifesciences leads in heart valves, with 17 on Michael's TA team.(05:59) Intelligence and innovation functions are early, with one analytics role in place.(07:58) The Valencia plant proves the strategy works and uncovers key process gaps.(10:11) TA taught the business the market's tough — now it's about how to act on it.(12:52) Quality of hire is the top priority, even if measurement still needs work.(15:12) TA priorities include field roles, tech optimization and guiding AI innovation.(17:01) Focus on doing the right thing, not on being liked.Resources Mentioned:Michael Petersonhttps://www.linkedin.com/in/taleadermichaelkpeterson/Edwards Lifesciences | LinkedInhttps://www.linkedin.com/company/edwards-lifesciences/Edwards Lifesciences | Websitehttps://www.edwards.com/This episode is brought to you by Sagemark HR.Sagemark HR can help you:✔ Improve your talent practices and make better, more informed people decisions.After 20+ years of experience leading Recruiting and Talent Acquisition across a wide variety of industries, I've seen enough hires (over 100,000 to date) to know that hiring decisions truly can make or break an organization.✔ Identify opportunities to not only improve your talent practices, but also delivering tangible business results.We understand every organization is different, and there's no one-size-fits-all magic solution. So we listen first and identify the gaps and sticking points in your current process before ever recommending a solution.✔ Bridge the gap from “traditional” to modern recruiting, without the painful learning curve.We believe recruiting, talent, and HR technology is a deep well of untapped business potential, and our mission is to help you identify and implement those hiring tools in a way that works for you.If you're interested in learning more, you can reach me at:www.sagemarkhr.com✉ ryan.dull@sagemarkhr.com#Talent #Recruiters #Recruiting #HRTech

The FDA has begun urging manufacturers to treat cybersecurity risk management as a material business concern. Hal Porter, Director of Consulting Services, Clearwater, speaks with Allyson Maur, Associate, McGuireWoods, about the implications of the FDA's growing focus on cybersecurity as a core component of medical device safety and financial risk and what that shift means for legal, compliance, and risk professionals. They discuss how manufacturers and providers should navigate these expectations, how legal teams can prepare for regulatory scrutiny, and how cyber risk in the device ecosystem is quickly becoming a board-level issue. Sponsored by Clearwater.Watch this episode: https://www.youtube.com/watch?v=3Y9R5kwRqeULearn more about Clearwater: https://clearwatersecurity.com/ Essential Legal Updates, Now in Audio AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast. Stay At the Forefront of Health Legal Education Learn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.

Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often miss. Rather than replacing doctors, AI enhances their ability to deliver more informed, precise, and efficient care. At the same time, individuals are gaining tools—from at-home diagnostics to wearable biosensors—that empower them to track and optimize their own health. This shift marks a move from reactive, disease-centered care to a proactive, data-driven model of scientific wellness. In this episode, I talk with Dr. Eric Topol, Dr. Nathan Price, Dr. Leroy Hood, Dr. Vijay Pande, and Daisy Wolf about how artificial intelligence, personalized data, and wearable technology are converging to radically transform medicine. Dr. Eric Topol is Executive Vice President of Scripps Research and founder/director of its Translational Institute, recognized as one of the top 10 most cited researchers in medicine with over 1,300 publications. A cardiologist and author of several bestselling books on the future of medicine, he leads major NIH grants in precision medicine and shares cutting-edge biomedical insights through his Ground Truths newsletter and podcast. Dr. Nathan Price is Chief Scientific Officer at Thorne HealthTech, author of The Age of Scientific Wellness, and a National Academy of Medicine Emerging Leader. He also serves on the Board on Life Sciences for the National Academies and is Affiliate Faculty in Bioengineering and Computer Science at the University of Washington. Dr. Leroy Hood is CEO and founder of Phenome Health, leading the Human Phenome Initiative to sequence and track the health of one million people over 10 years. A pioneer in systems biology and co-founder of 17 biotech companies, he is a recipient of the Lasker Prize, Kyoto Prize, and National Medal of Science. Dr. Vijay Pande is a General Partner at Andreessen Horowitz and founder of a16z Bio + Health, managing over $3 billion in life sciences and healthcare investments at the intersection of biology and AI. An Adjunct Professor at Stanford, he is known for his work in computational science, earning honors like the DeLano Prize and a Guinness World Record for Folding@Home. Daisy Wolf is an investing partner at Andreessen Horowitz, specializing in healthcare AI, consumer health, and healthcare-fintech innovation. She previously worked at Meta and in various startups, holds a JD from Yale Law, an MBA from Stanford, and a BA from Yale, and is based in New York City. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN10 to save 10%. Full-length episodes can be found here: Can AI Fix Our Health and Our Healthcare System? The Next Revolution In Medicine: Scientific Wellness, AI And Disease Reversal The Future of Healthcare: The Role of AI and Technology

Structural heart innovation is rewriting the future of cardiovascular care—delivering faster recoveries, better outcomes, and a new standard of precision through less invasive procedures. Breakthroughs in imaging, smarter device design, and real-time data are empowering doctors to tackle even the most complex heart conditions with unmatched accuracy. Leading this heart-health revolution is Edwards Lifesciences, a global pioneer changing the way the world treats cardiovascular disease. CEO Bernard Zovighian goes Inside the ICE House to discuss how, under his leadership, the company is breaking boundaries and saving lives - pne innovation at a time.

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

Aligning Culture, Talent & Strategy for Scalable Growth with Dr. Kallol Biswas, Ph.D. In this powerful episode of The Hurricane H Show, we sit down with Dr. Kallol Biswas, Ph.D. — a global leadership expert, Principal Consultant, and Fractional Executive with over 20 years of experience leading high-performance teams across pharma, biotech, and medical devices. Together, we explore how organizations can align culture, talent, and business strategy to unlock scalable growth — especially in today's fast-evolving, innovation-driven world. Dr. Biswas shares key insights on transforming technical leaders into strategic influencers, building trust across global teams, and the growing role of fractional leadership in regulated industries. Whether you're a CEO, team leader, HR executive, or an emerging professional in life sciences, this episode will shift how you view leadership, execution, and long-term performance. Topics Covered: Leadership transformation in pharma & biotech Aligning culture with strategy and execution Fractional executive insights Scaling high-performance teams globally The future of life sciences leadership

3,500 years ago, cats started showing up in Egyptian paintings on tomb walls and in sculptures and carvings. Not only were they abundant in these representations, but it was very clear that they were domestic. They had collars around their necks and were eating out of food dishes underneath the dining room table. That scene is not so different from the life many cats lead today. So how did cats go from the wild to being immortalized on tomb wall paintings and lounging on living room couches? And just how domestic is a domestic cat?Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Links to the Tiny Show and Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.